{"id":819886,"date":"2025-02-28T08:05:34","date_gmt":"2025-02-28T13:05:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/"},"modified":"2025-02-28T08:05:34","modified_gmt":"2025-02-28T13:05:34","slug":"anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/","title":{"rendered":"Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays"},"content":{"rendered":"
\n

MINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025 (GLOBE NEWSWIRE) — Anteris<\/strong>\u00ae<\/strong><\/sup> Technologies Global Corp.<\/strong> (Anteris <\/strong>or the Company<\/strong>) (NASDAQ: AVR, ASX: AVR) a structural heart company developing DurAVR\u00ae<\/sup>\u00a0THV, a first-in-class, biomimetic, balloon expandable heart valve, is pleased to advise that Chief Executive Officer, Wayne Paterson will be presenting at both the 45th<\/sup> Annual TD Cowen Healthcare Conference, and the Barclays 27th<\/sup> Annual Global Healthcare Conference.<\/p>\n

The details of each conference and how to access them are as follows:<\/p>\n\n\n\n\n\n\n\n\n
\n TD Cowen 45<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n Annual Healthcare Conference<\/strong>\n <\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n Wednesday, March 5<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n , 2025 (US time)<\/strong>\n <\/td>\n<\/tr>\n
Format:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nFireside chat with analyst, Joshua Jennings, and 1×1 meetings<\/td>\n<\/tr>\n
Time:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n9:10-9:40AM (US EST)<\/td>\n<\/tr>\n
Room:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nProvincetown, 4th<\/sup> Floor<\/td>\n<\/tr>\n
Location:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nMarriott Copley Plaza, Boston, MA<\/td>\n<\/tr>\n
Webcast link:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n https:\/\/wsw.com\/webcast\/cowen177\/avr.ax\/2275728<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n
In addition, Anteris Chief Medical Officer, Dr. Chris Meduri, MD, MPH, will be one of the expert panelists on the Structural Heart-TAVR panel discussion moderated by Joshua Jennings.\u00a0<\/p>\n\n\n\n\n\n\n
\n Date:<\/strong>\n <\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n Wednesday, March 5<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n , 2025 (US time)<\/strong>\n <\/td>\n<\/tr>\n
Format:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nPanel discussion<\/td>\n<\/tr>\n
Time:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n3:10-4:10PM (US EST)<\/td>\n<\/tr>\n
Room:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nSalon D, 4th Floor<\/td>\n<\/tr>\n
Location:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nMarriott Copley Plaza, Boston, MA<\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n\n\n\n\n\n\n\n\n
\n Barclays 27th<\/strong><\/sup> Annual Global Healthcare Conference<\/strong><\/strong>\n <\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n Tuesday, March 11th, 2025 (US time)<\/strong>\n <\/td>\n<\/tr>\n
Format:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nFireside chat with analyst, Matt Miksic, and 1×1 meetings<\/td>\n<\/tr>\n
Time:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n9:00-9:25AM (US EST)<\/td>\n<\/tr>\n
Room:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nAmericana 3 (Track 3)<\/td>\n<\/tr>\n
Location:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nLoews Miami Beach, Miami, FL<\/td>\n<\/tr>\n
Webcast link:<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n https:\/\/cc.webcasts.com\/barc002\/031125a_js\/?entity=80_U2ODGGH<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

\n
The webcasts of the TD Cowen and Barclays fireside chats can be accessed by visiting the Investor Center section of the Company\u2019s website at https:\/\/anteristech.com\/investors\/investor-presentations.html<\/a>. A replay of the webcast will be archived for up to 90 days.<\/p>\n

\n About Anteris<\/strong>\n <\/p>\n

Anteris\u00ae<\/sup> Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.<\/p>\n

Anteris\u2019 lead product, the DurAVR\u00ae<\/sup> Transcatheter Heart Valve (THV<\/strong>), was designed in partnership with the world\u2019s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis \u2013 a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR\u00ae<\/sup> THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. DurAVR\u00ae <\/sup>THV is made using a single piece of molded ADAPT\u00ae<\/sup> tissue, Anteris\u2019 patented anti-calcification tissue technology. ADAPT\u00ae<\/sup> tissue, which is FDA-cleared, has been used clinically for over 10\u00a0years and distributed for use in over 55,000 patients worldwide. The DurAVR\u00ae<\/sup> THV System is comprised of the DurAVR\u00ae<\/sup> valve, the ADAPT\u00ae<\/sup> tissue, and the balloon-expandable ComASUR\u00ae<\/sup> Delivery System.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This announcement contains forward-looking statements. Forward-looking statements include all statements that are not historical facts. Forward-looking statements generally are identified by the words \u201cbelieve,\u201d \u201cproject,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cintend,\u201d \u201cbudget,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201cstrategy,\u201d \u201cplan,\u201d \u201cguidance,\u201d \u201coutlook,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cwill be,\u201d \u201cwill continue,\u201d \u201cwill likely result\u201d and similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described under \u201cRisk Factors\u201d in Anteris\u2019 registration statement filed on 10 December 2024 with the SEC and ASX. Readers are cautioned not to put undue reliance on forward-looking statements, and except as required by law, neither ATL or Anteris assume any obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.<\/p>\n

\n Authorisation and Additional information<\/strong>\n <\/p>\n

This announcement was authorised for release on the ASX by the Disclosure Committee of Anteris.<\/p>\n\n\n\n\n\n\n\n\n
\n For more information:<\/strong>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Investor Relations (Global)<\/strong>\n <\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\n Investor Relations (US)<\/strong>\n <\/td>\n<\/tr>\n
investors@anteristech.com<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nmchatterjee@bplifescience.com<\/td>\n<\/tr>\n
Debbie Ormsby<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nMalini Chatterjee, Ph.D.<\/td>\n<\/tr>\n
Anteris Technologies Global Corp.<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nBlueprint Life Science Group<\/td>\n<\/tr>\n
+61 1300 550 310 | +61 7 3152 3200<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n+1 917 330 4269<\/td>\n<\/tr>\n<\/table>\n

\n \n <\/p>\n\n\n\n\n\n
Website<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nwww.anteristech.com<\/td>\n<\/tr>\n
X<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n@AnterisTech<\/td>\n<\/tr>\n
Facebook<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nwww.facebook.com\/anteristech<\/td>\n<\/tr>\n
LinkedIn\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\nhttps:\/\/www.linkedin.com\/company\/anteristech<\/td>\n<\/tr>\n<\/table>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025 (GLOBE NEWSWIRE) — Anteris\u00ae Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a structural heart company developing DurAVR\u00ae\u00a0THV, a first-in-class, biomimetic, balloon expandable heart valve, is pleased to advise that Chief Executive Officer, Wayne Paterson will be presenting at both the 45th Annual TD Cowen Healthcare Conference, and the Barclays 27th Annual Global Healthcare Conference. The details of each conference and how to access them are as follows: TD Cowen 45 th Annual Healthcare Conference Date: \u00a0 \u00a0 Wednesday, March 5 th , 2025 (US time) Format: \u00a0 \u00a0 Fireside chat with analyst, Joshua Jennings, and 1×1 meetings Time: \u00a0 \u00a0 9:10-9:40AM (US EST) Room: \u00a0 \u00a0 Provincetown, 4th Floor … <\/p>\n

Continue reading “Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-819886","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAnteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025 (GLOBE NEWSWIRE) — Anteris\u00ae Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a structural heart company developing DurAVR\u00ae\u00a0THV, a first-in-class, biomimetic, balloon expandable heart valve, is pleased to advise that Chief Executive Officer, Wayne Paterson will be presenting at both the 45th Annual TD Cowen Healthcare Conference, and the Barclays 27th Annual Global Healthcare Conference. The details of each conference and how to access them are as follows: TD Cowen 45 th Annual Healthcare Conference Date: \u00a0 \u00a0 Wednesday, March 5 th , 2025 (US time) Format: \u00a0 \u00a0 Fireside chat with analyst, Joshua Jennings, and 1×1 meetings Time: \u00a0 \u00a0 9:10-9:40AM (US EST) Room: \u00a0 \u00a0 Provincetown, 4th Floor … Continue reading "Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-28T13:05:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays\",\"datePublished\":\"2025-02-28T13:05:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/\"},\"wordCount\":665,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/\",\"name\":\"Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=\",\"datePublished\":\"2025-02-28T13:05:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/","og_locale":"en_US","og_type":"article","og_title":"Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays - Market Newsdesk","og_description":"MINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025 (GLOBE NEWSWIRE) — Anteris\u00ae Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a structural heart company developing DurAVR\u00ae\u00a0THV, a first-in-class, biomimetic, balloon expandable heart valve, is pleased to advise that Chief Executive Officer, Wayne Paterson will be presenting at both the 45th Annual TD Cowen Healthcare Conference, and the Barclays 27th Annual Global Healthcare Conference. The details of each conference and how to access them are as follows: TD Cowen 45 th Annual Healthcare Conference Date: \u00a0 \u00a0 Wednesday, March 5 th , 2025 (US time) Format: \u00a0 \u00a0 Fireside chat with analyst, Joshua Jennings, and 1×1 meetings Time: \u00a0 \u00a0 9:10-9:40AM (US EST) Room: \u00a0 \u00a0 Provincetown, 4th Floor … Continue reading \"Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-28T13:05:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays","datePublished":"2025-02-28T13:05:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/"},"wordCount":665,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/","name":"Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=","datePublished":"2025-02-28T13:05:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjU4NyM2NzgzODcwIzIyNjIyMTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anteris-to-present-at-healthcare-investor-conferences-td-cowen-and-barclays\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=819886"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819886\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=819886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=819886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=819886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}